Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00946218 · ClinicalTrials.gov registry record
Diagnosis and Characterization of Dengue Fever in Children
A clinical trial, sponsored by St. Jude Children's Research Hospital.
- Completed
- Registry status
- 258
- Enrollment target
NCT00946218 is a clinical trial that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 258 participants.
The verdict
NCT00946218 has completed, sponsored by St. Jude Children's Research Hospital.
- COMPLETED
- Registry status
- 258 participants
- Enrollment target
Study Summary
Dengue virus is an arbovirus transmitted by mosquitoes which causes significant morbidity and mortality among children in tropical regions, especially in resource limited countries. The objective of this protocol is to compare the sensitivity and specificity of clinical gestalt and two rapid antigen tests for dengue virus and to compare the gene expression of leukocytes in distinct dengue fever disease phenotypes module-based RNA microarray technology.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 258 participants |
| Start Date | 2009-07 |
| Est. Completion | 2009-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00946218
The ClinicalTrials.gov registry entry for NCT00946218 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 258 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00946218 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00946218 about?
NCT00946218 is a clinical study titled "Diagnosis and Characterization of Dengue Fever in Children". Dengue virus is an arbovirus transmitted by mosquitoes which causes significant morbidity and mortality among children in tropical regions, especially in resource limited countries. The objective of this protocol is to compare the sensitivity and specificity of clinical gestalt and two rapid antigen...
What is the current status of trial NCT00946218?
This trial is currently completed. The enrollment target is 258 participants. The study started on 2009-07. Estimated completion is 2009-12.
Who is sponsoring clinical trial NCT00946218?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.